HomeSynairgen shares bounce 30% as SNG001 shown to accelerate COVID-19 recoveryCOVID-19 immunity treatment Synairgen SNG001

COVID-19 immunity treatment Synairgen SNG001

Most Read

All eyes on Sainsbury’s strategy as full-year results are released

19/04/2024

FTSE 100 plays catch up with US stocks on commodity strength

18/04/2024

easyJet shares rise as passenger numbers take off and losses fall in first half

18/04/2024

AIM movers: Surgical Innovations plans improved efficiency and ex-dividends

18/04/2024